Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMMY C VICK

Allopathic & Osteopathic Physicians Urology

NPI
1174528459
CMS profile
8256
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$8,807.16

  • Reported across 200 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$475.16

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $475.16 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,751.43 52
PY2019 $1,368.29 31
PY2020 $830.81 14
PY2021 $1,204.14 35
PY2022 $1,075.25 27
PY2023 $1,102.08 25
PY2024 $475.16 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
180 Medical, Inc. $27.49 05/16/2024 Food and Beverage Undisputed 01/23/2026 1151365722 CMS
Antares Pharma, Inc. $16.95 01/16/2024 Food and Beverage Undisputed 01/23/2026 1146491257 CMS
Astellas Pharma US Inc $18.85 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139275448 CMS
Astellas Pharma US Inc $14.69 04/25/2024 Food and Beverage Undisputed 01/23/2026 1139332320 CMS
Boston Scientific Corporation $18.24 05/07/2024 Food and Beverage Undisputed 01/23/2026 1092636033 CMS
Boston Scientific Corporation $26.77 07/24/2024 Food and Beverage Undisputed 01/23/2026 1092636035 CMS
COLOPLAST CORP $16.78 04/24/2024 Food and Beverage Undisputed 01/23/2026 1117430210 CMS
COLOPLAST CORP $31.81 10/09/2024 Food and Beverage Undisputed 01/23/2026 1117430277 CMS
COLOPLAST CORP $129.25 10/30/2024 Food and Beverage Undisputed 01/23/2026 1117430256 CMS
COLOPLAST CORP $25.36 11/06/2024 Food and Beverage Undisputed 01/23/2026 1117430260 CMS
ConvaTec Inc. $58.33 02/29/2024 Food and Beverage Undisputed 01/23/2026 1151386568 CMS
Laborie Medical Technologies Corp. $19.78 03/21/2024 Food and Beverage Undisputed 01/23/2026 1154325527 CMS
Myriad Genetic Laboratories, Inc. $20.61 09/10/2024 Food and Beverage Undisputed 01/23/2026 1152541863 CMS
Teleflex LLC $14.14 02/20/2024 Food and Beverage Undisputed 01/23/2026 1142089931 CMS
Tolmar, Inc. $13.67 12/03/2024 Food and Beverage Undisputed 01/23/2026 1138704568 CMS
UROGEN PHARMA, INC. $22.44 04/22/2024 Food and Beverage Undisputed 01/23/2026 1137928290 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.